Prof Peter Revill
Honorary (Professorial Fellow)
Department of Infectious Diseases
183 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B
DOI: 10.1093/infdis/jiaf5692026
Journal article
Overview of gene editing strategies against HBV
DOI: 10.1016/j.antiviral.2026.1063552026
Journal article
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
DOI: 10.1093/cid/ciaf2812025
Journal article
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV–hepatitis B virus co-infection model system
DOI: 10.1128/spectrum.00809-252022
Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Research grants (other domestic)
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Internal Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
RECENT SCHOLARLY WORKS
2024
Journal article
Availability of point-of-care HBV tests in resource-limited settings
DOI: 10.1016/S2468-1253(24)00308-X2024
Journal article
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
DOI: 10.1016/j.jhep.2024.05.0252024
Conference Proceedings
ANTI- HBS IMMUNE COMPLEX LEVELS: A NOVEL BIOMARKER OF HEPATITIS FLARE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B WHO STOP NUCLEOS( T) IDE ANALOGUE THERAPY
2024
Journal article
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
DOI: 10.1111/liv.160292024
Conference Proceedings
Anti-HBs immune complex levels: A novel biomarker of hepatitis flare in patients with HBeAg-negative chronic hepatitis B who stop nucleos(t)ide analogue therapy
2024
Journal article
The impact of hepatitis B virus (HBV) splicing on HBV replication and disease progression
DOI: 10.37349/edd.2024.00054
RECENT PROJECTS
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B